NSEDCP
BHVN
NJ State Employees Deferred Compensation Plan’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-20,500
| Closed | -$3.1M | – | 492 |
|
|
2022
Q3 | $3.1M | Hold |
20,500
| – | – | 0.53% | 44 |
|
|
2022
Q2 | $2.99M | Hold |
20,500
| – | – | 0.49% | 52 |
|
|
2022
Q1 | $2.43M | Hold |
20,500
| – | – | 0.33% | 76 |
|
|
2021
Q4 | $2.83M | Hold |
20,500
| – | – | 0.36% | 72 |
|
|
2021
Q3 | $2.85M | Hold |
20,500
| – | – | 0.39% | 67 |
|
|
2021
Q2 | $1.99M | Hold |
20,500
| – | – | 0.26% | 95 |
|
|
2021
Q1 | $1.4M | Buy |
20,500
+5,500
| +37% | +$376K | 0.2% | 119 |
|
|
2020
Q4 | $1.29M | Hold |
15,000
| – | – | 0.2% | 119 |
|
|
2020
Q3 | $975K | Hold |
15,000
| – | – | 0.18% | 121 |
|
|
2020
Q2 | $1.1M | Hold |
15,000
| – | – | 0.21% | 107 |
|
|
2020
Q1 | $510K | Hold |
15,000
| – | – | 0.12% | 169 |
|
|
2019
Q4 | $817K | Hold |
15,000
| – | – | 0.14% | 151 |
|
|
2019
Q3 | $626K | Buy |
15,000
+9,000
| +150% | +$376K | 0.11% | 180 |
|
|
2019
Q2 | $263K | Buy |
+6,000
| New | +$263K | 0.05% | 465 |
|